Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or Proctosigmoiditis

BACKGROUND: Budesonide foam, a rectally administered, second-generation corticosteroid with extensive hepatic first-pass metabolism, is efficacious for the treatment of mild-to-moderate ulcerative proctitis and ulcerative proctosigmoiditis. AIM: The aim of this study was to comprehensively assess th...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubin, David T., Sandborn, William J., Bosworth, Brian, Zakko, Salam, Gordon, Glenn L., Sale, Mark E., Rolleri, Robert L., Golden, Pamela L., Barrett, Andrew C., Bortey, Enoch, Forbes, William P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621699/
https://www.ncbi.nlm.nih.gov/pubmed/26386854
http://dx.doi.org/10.1007/s10620-015-3868-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621699/
https://www.ncbi.nlm.nih.gov/pubmed/26386854
http://dx.doi.org/10.1007/s10620-015-3868-5

Ejemplares similares